Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 10-Apr-24 1:06 PM View:  | Karas Douglas John Director | Nascent Biotech Inc. (NBIO) | 31-Mar-24 | Acquisition (other) | 27,100 | $0.18 | $4,999.95 | 2% 1.74M to 1.77M | |
| 10-Apr-24 1:07 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 31-Mar-24 | Acquisition (other) | 112,500 | $0.18 | $20,756.20 | < 1% 11.8M to 11.91M | |
| 10-Apr-24 1:06 PM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 31-Mar-24 | Acquisition (other) | 225,000 | $0.18 | $41,512.50 | < 1% 22.71M to 22.93M | |
| 27-Feb-24 1:46 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 29-Dec-23 | Acquisition (other) | 119,650 | $0.17 | $20,340.50 | 1% 11.68M to 11.8M | |
| 27-Feb-24 1:46 PM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 29-Dec-23 | Acquisition (other) | 239,300 | $0.17 | $40,681.00 | 1% 22.47M to 22.71M | |
| 27-Feb-24 1:45 PM View: | Karas Douglas John Director | Nascent Biotech Inc. (NBIO) | 29-Dec-23 | Acquisition (other) | 28,935 | $0.18 | $5,208.30 | 2% 1.72M to 1.74M | |
| 09-Nov-23 2:22 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 29-Sep-23 | Acquisition (other) | 1,386,300 | $0.12 | $173,288.00 | 13% 10.29M to 11.68M | |
| 09-Nov-23 2:21 PM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 29-Sep-23 | Acquisition (other) | 2,772,600 | $0.12 | $346,575.00 | 14% 19.7M to 22.47M | |
| 09-Nov-23 2:22 PM View: | Karas Douglas John Director | Nascent Biotech Inc. (NBIO) | 29-Sep-23 | Acquisition (other) | 39,750 | $0.12 | $4,968.75 | 2% 1.68M to 1.72M | |
| 13-Jul-23 11:26 AM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 29-Jun-23 | Gift | 700,000 | $0.05 | $34,300.00 | (6%) 10.99M to 10.29M | |
| 14-Jul-23 8:42 AM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 29-Jun-23 | Gift | 960,000 | $0.05 | $48,000.00 | (5%) 20.66M to 19.7M | |
| 09-Jun-23 3:28 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 07-Jun-23 | Purchase | 130,000 | $0.04 | $5,200.00 | 1% 10.28M to 10.41M | |
| 09-Jun-23 3:28 PM View: | Karas Douglas John Director | Nascent Biotech Inc. (NBIO) | 31-Mar-23 | Acquisition (other) | 89,285 | $0.06 | $5,357.10 | 6% 1.49M to 1.58M | |
| 09-Jun-23 3:28 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 31-Mar-23 | Acquisition (other) | 581,000 | $0.06 | $34,860.00 | 6% 9.7M to 10.28M | |
| 09-Jun-23 3:27 PM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 31-Mar-23 | Acquisition (other) | 1,167,000 | $0.06 | $70,020.00 | 6% 18.07M to 19.23M | |
| 14-Feb-23 6:22 AM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 09-Feb-23 | Gift | 700,000 | $0.12 | $84,000.00 | (7%) 10.5M to 9.8M | |
| 02-Feb-23 12:47 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 27-Jan-23 | Purchase | 20,000 | $0.14 | $2,800.00 | < 1% 10.4M to 10.42M | |
| 02-Feb-23 3:04 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 27-Jan-23 | Purchase Duplicate | 20,000 | $0.14 | $2,800.00 | < 1% 10.4M to 10.42M | |
| 03-Jan-23 3:08 PM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 30-Dec-22 | Acquisition (other) | 462,000 | $0.20 | $92,400.00 | 3% 17.61M to 18.07M | |
| 03-Jan-23 3:08 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 30-Dec-22 | Grant | 231,000 | $0.20 | $46,200.00 | 2% 10.17M to 10.4M | |
| 03-Jan-23 3:09 PM View: | Karas Douglas John Director | Nascent Biotech Inc. (NBIO) | 30-Dec-22 | Acquisition (other) | 25,000 | $0.20 | $5,000.00 | 2% 1.46M to 1.49M | |
| 25-Jul-22 11:24 AM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 21-Jul-22 | Sale | 5,000 | $0.26 | $1,300.00 | (< 1%) 10.14M to 10.13M | |
| 19-Apr-22 9:58 AM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 14-Apr-22 | Gift | 700,000 | $0.08 | $56,000.00 | (8%) 8.98M to 8.28M | |
| 04-Apr-22 4:01 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 31-Mar-22 | Acquisition (other) | 215,000 | $0.06 | $12,040.00 | 2% 10.77M to 10.98M | |
| 04-Apr-22 4:01 PM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 31-Mar-22 | Acquisition (other) | 430,000 | $0.06 | $24,080.00 | 3% 17.02M to 17.45M | |
| 04-Apr-22 4:01 PM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 09-Mar-22 | Acquisition (other) | 1,000,000 | $0.05 | $50,000.00 | 6% 16.02M to 17.02M | |
| 04-Apr-22 4:01 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 09-Mar-22 | Acquisition (other) | 1,100,000 | $0.05 | $55,000.00 | 11% 9.67M to 10.77M | |
| 04-Apr-22 4:01 PM View: | Karas Douglas John Director | Nascent Biotech Inc. (NBIO) | 09-Mar-22 | Acquisition (other) | 300,000 | $0.05 | $15,000.00 | 27% 1.13M to 1.43M | |
| 08-Feb-22 5:07 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 07-Jan-22 | Gift | 1,700,000 | $0.05 | $85,000.00 | (14%) 12.24M to 10.54M | |
| 20-Aug-21 9:50 AM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 30-Jun-21 | Disposition (other) | 700,000 | $0.10 | $73,500.00 | (4%) 18.21M to 17.51M | |
| 08-Feb-22 5:06 PM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 30-Jun-21 | Acquisition (other) | 347,400 | $0.10 | $36,477.00 | 2% 15.67M to 16.02M | |
| 08-Feb-22 5:07 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 30-Jun-21 | Acquisition (other) | 173,700 | $0.10 | $18,238.50 | 1% 12.07M to 12.24M | |
| 20-Aug-21 9:48 AM View: | Karas Douglas John Director | Nascent Biotech Inc. (NBIO) | 30-Jun-21 | Acquisition (other) | 83,334 | $0.10 | $8,750.07 | 8% 1.04M to 1.13M | |
| 20-Aug-21 9:50 AM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 30-Jun-21 | Acquisition (other) | 173,700 | $0.06 | $10,595.70 | < 1% 18.04M to 18.21M | |
| 20-Aug-21 9:49 AM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 30-Jun-21 | Acquisition (other) Duplicate | 347,400 | $0.10 | $36,477.00 | 2% 15.67M to 16.02M | |
| 08-Feb-22 5:07 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 15-Apr-21 | Gift | 1,700,000 | $0.05 | $85,000.00 | (12%) 13.77M to 12.07M | |
| 20-Aug-21 9:48 AM View: | Karas Douglas John Director | Nascent Biotech Inc. (NBIO) | 09-Apr-21 | Acquisition (other) | 307,010 | $0.08 | $23,332.80 | 42% 737.51K to 1.04M | |
| 06-Apr-21 12:28 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 31-Mar-21 | Acquisition (other) | 810,000 | $0.06 | $49,410.00 | 8% 9.56M to 10.37M | |
| 06-Apr-21 12:31 PM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 31-Mar-21 | Acquisition (other) | 1,620,000 | $0.06 | $98,820.00 | 12% 14.05M to 15.67M | |
| 06-Apr-21 12:32 PM View: | Karas Douglas John Director | Nascent Biotech Inc. (NBIO) | 31-Mar-21 | Acquisition (other) | 83,334 | $0.07 | $5,833.38 | 12% 689.89K to 773.22K | |
| 06-Apr-21 12:28 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 26-Mar-21 | Acquisition (other) | 1,000,000 | $0.06 | $60,000.00 | 12% 8.56M to 9.56M | |
| 06-Apr-21 12:31 PM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 26-Mar-21 | Acquisition (other) | 1,250,000 | $0.06 | $75,000.00 | 10% 12.8M to 14.05M | |
| 11-Jan-21 5:00 PM View: | Karas Douglas John Director | Nascent Biotech Inc. (NBIO) | 31-Dec-20 | Acquisition (other) | 108,460 | $0.05 | $4,989.16 | 19% 581.43K to 689.89K | |
| 11-Jan-21 5:00 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 31-Dec-20 | Acquisition (other) | 1,442,000 | $0.05 | $66,476.20 | 20% 7.12M to 8.56M | |
| 11-Jan-21 5:00 PM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 31-Dec-20 | Acquisition (other) | 2,884,000 | $0.05 | $132,952.00 | 29% 9.92M to 12.8M | |
| 11-Jan-21 5:00 PM View: | Karas Douglas John Director | Nascent Biotech Inc. (NBIO) | 20-Nov-20 | Acquisition (other) | 350,000 | $0.05 | $17,500.00 | 151% 231.49K to 581.49K | |
| 11-Jan-21 5:00 PM View: | Holden Lowell Thomas CFO Director | Nascent Biotech Inc. (NBIO) | 30-Sep-20 | Acquisition (other) | 127,970 | $0.07 | $8,957.90 | 2% 6.99M to 7.12M | |
| 11-Jan-21 5:00 PM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 30-Sep-20 | Acquisition (other) | 218,715 | $0.10 | $21,871.50 | 2% 9.7M to 9.92M | |
| 11-Jan-21 5:00 PM View: | Karas Douglas John Director | Nascent Biotech Inc. (NBIO) | 30-Sep-20 | Acquisition (other) | 71,430 | $0.07 | $5,000.10 | 45% 160.06K to 231.49K | |
| 02-Jul-20 1:33 PM View: | Carrick Sean President & CEO Director 10% Owner | Nascent Biotech Inc. (NBIO) | 29-Jun-20 | Acquisition (other) | 889,000 | $0.10 | $88,900.00 | 5% 17.62M to 18.51M |
